Differential immune response to influenza and pneumococcal vaccination in immunosuppressed patients after heart transplantation

Transplantation

Volumn 66, Issue 10, 1998, Pages 1340-1347

  Dengler, Thomas J ^a,b   Strnad, Nicola ^c   Buhring, Irina ^c   Zimmermann, Rainer ^a   Girgsdies, Otto ^d   Kubler, Wolfgang E ^a   Zielen, Stefan ^c  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GOETHE UNIVERSITY   (Germany)

^d Chiron Behring GmbH & Co   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

ADULT; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART TRANSPLANTATION; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA; INFLUENZA VACCINATION; MALE; PRIORITY JOURNAL; SPLENECTOMY; STREPTOCOCCUS PNEUMONIAE;

EID: 0032573523     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199811270-00014     Document Type: Article

References (55)

1. Carey W, Pimentel R, Westveer MK, Vogt D, Broughan T. Failure of hepatitis B immunization in liver transplant recipients: results of a prospective trial. Am J Gastroenterol 1990; 85: 1590.
2. Lefebure AF, Verpooten GA, Couttenye MM, De Broe ME. Immunogenicity of a recombinant DNA hepatitis B vaccine in renal transplant patients. Vaccine 1993; 11: 397.
3. Wagner D, Wagenbreth I, Stachan-Kunstyr R, Thoma HA, Hemmerling HE, Flik J. Hepatitis B vaccination of immunosuppressed heart transplant recipients with the vaccine Hepa gene 3. Clin Invest 1994; 72 (5): 350.
4. Amber IJ, Gilbert EM, Schiffmann G, Jacobson JA. Increased risk of pneumococcal infections in cardiac transplant recipients. Transplantation 1990; 49: 122.
5. Laufer G, Laczkovics A, Wollenek G, et al. Infectious complications in heart transplant recipients with combined low dose cyclosporine, azathioprine and prednisolone immunosuppression. Transplant Proc 1989; 21: 2508.
6. Mermel LA, Maki DG. Bacterial pneumonia in solid organ transplantation. Semin Respir Infect 1990; 5: 10.
7. Mufson MA. Streptococcus pneumoniae. In: Mandell GL, Douglas RG, Bennett JE, eds. Principles and practice of infectious diseases. New York: Churchill Livingstone, 1995; 1539.
8. Embrey RP, Geist LJ. Influenza A pneumonitis following treatment of acute cardiac allograft rejection with murine monoclonal anti-CD3 antibody (OKT3). Chest 1995; 108: 1456.
9. Apalsch AM, Green M, Ledesma Medina J, Nour B, Wald ER. Parainfluenza and influenza virus infections in pediatric organ transplant recipients. Clin Infect Dis 1995; 20: 394.
10. Whimbey E, Elting LS, Couch RB, et al. Influenza A virus infections among hospitalized adult bone marrow transplant recipients. Bone Marrow Transplant 1994; 13: 437.
11. Aschan J, Ringden O, Ljungman P, Andersson J, Lewensohn Fuchs I, Forsgren M. Influenza B in transplant patients. Scand J Infect Dis 1989; 21: 349.
12. Campbell DS, Rumley MH. Cost-effectiveness of the influenza vaccine in a healthy, working-age population. J Occup Environ Med 1997; 39: 408.
13. Kubiet MA, Gonzalez Rothi RJ, Cottey R, Bender BS. Serum antibody response to influenza vaccine in pulmonary patients receiving corticosteroids. Chest 1996; 110: 367.
14. Grekas D, Alivanis P, Kotzadamis N, Kiriazopoulou V, Pyrpasopoulos M, Tourkantonis A. Influenza vaccination in chronic hemodialysis patients: the effect of zinc supplementation. Renal Fail 1992; 14: 575.
15. Ahmed F, Steinhoff MC, Rodriguez Barradas MC, Hamilton RG, Musher DM, Nelson KE. Effect of human immunodeficiency virus type 1 infection on the antibody response to a glycoprotein conjugate pneumococcal vaccine: results from a randomized trial. J Infect Dis 1996; 173: 83.
16. Versluis DJ, Beyer WE, Masurel N, Wenting GJ, Weimar W. Impairment of the immune response to influenza vaccination in renal transplant recipients by cyclosporine, but not azathioprine. Transplantation 1986; 42: 376.
17. Edvardsson VO, Flynn JT, Deforest A, et al. Effective immunization against influenza in pediatric renal transplant recipients. Clin Transplant 1996; 10: 556.
18. Blumberg EA, Albano C, Pruett T, et al. The immunogenicity of influenza virus vaccine in solid organ transplant recipients. Clin Infect Dis 1996; 22: 295.
19. Griffioen AW, Sanders L, Rijkers GT, Zegers BJ. Cell biology of B lymphocyte activation by polysaccharides. J Infect Dis 1992; 165: 571.
20. Billingham ME, Cary NR, Hammond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group;. International Society for Heart Transplantation. J Heart Transplant 1990; 9: 587.
21. Zielen S, Broeker M, Strnad N, et al. Simple determination of polysaccharide specific antibodies by means of chemically modified ELISA plates. J Immunol Methods 1996; 193: 1.
22. Sankilampi U, Honkanen P, Bloigu A, Herva E, Leinonen M. Antibody response to pneumococcal polysaccharide vaccine in the elderly. J Infect Dis 1996; 173: 387.
23. Siber GR, Priehs C, Madore DV. Standardisation of antibody assays for measuring the response to pneumococcal infection and immunization. Pediatr Infect Dis J 1989; 8: S84.
24. Bruyn GAW, van Furth R. Pneumococcal polysaccharide vaccines: indications, efficacy and recommendations. Eur J Microbiol Infect Dis 1991; 10: 897.
25. Barkholt LB, Ericson BG, Tollemar J, et al. Infections in human liver recipients: different patterns early and late after transplantation. Transplant Int 1993; 6: 77.
26. Petri WJ. Infections in heart transplant recipients. Clin Infect Dis 1994; 18: 141.
27. Parkkali T, Ruutu T, Stenvik M, et al. Loss of protective immunity to polio, diphtheria and Haemophilus influenzas type b after allogeneic bone marrow transplantation. APMIS 1996; 104: 383.
28. Linnemann CJ, First MR, Schiffmann G. Revaccination of renal transplant and hemodialysis recipients with pneumococcal vaccine. Arch Intern Med 1986; 146: 1554.
29. Reinert RR, Queck A, Kaufhold A, Kresken M, Luetticken R. Antibiotic sensitivity of Streptococcus pneumoniae isolated from normally sterile body sites: first results of a multicenter study in Germany. Infection 1994; 22: 113.
30. Appelbaum PC. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1992; 15: 77.
31. Centers for Disease Control. Pneumococcal polysaccharide vaccine. MMWR 1989; 38: 64.
32. Lortan JE, Vellodi A, Jurges ES, Hugh Jones K. Class- and subclass-specific pneumococcal antibody levels and response to immunization after bone marrow transplantation. Clin Exp Immunol 1992; 88: 512.
33. Giebink GS, Warkentin PI, Ramsay NK, Kersey JH. Titers of antibody to pneumococci in allogeneic bone marrow transplant recipients before and after vaccination with pneumococcal vaccine. J Infect Dis 1986; 154: 590.
34. Landesman SH, Schiffmann G. Assessment of the antibody response to pneumococcal vaccine in high-risk populations. Rev Infect Dis 1981; 3: S184.
35. Arnold WC, Steele RW, Rastogi SP, Flanigan WJ. Response to pneumococcal vaccine in renal allograft recipients. Am J Nephrol 1985; 5: 30.
36. Sanders EA, Rijkers GT, Griffioen AW, Kuis W, Zegers BJ. T cell function in patients with impaired antibody responses to polysaccharide antigens. Eur J Immunol 1991; 21: 2293.
37. Dengler TJ, Strnad N, Zimmermann R, et al. Pneumococcal vaccination after heart and liver transplantation: immune responses in immunosuppressed patients and in healthy controls. Dtsch Med Wochenschr 1996; 121: 1519.
38. Rose DN, Schechter CB, Sacks HS. Influenza and pneumococcal vaccination of HIV-infected patients: a policy analysis. Am J Med 1993; 94: 160.
39. Obaro SK, Henderson DC, Monteil M. Immunity to pneumococcal infections. Lancet 1995; 345: 70.
40. Avanzini MA, Carra AM, Maccario R, et al. Antibody response to pneumococcal vaccine in children receiving bone marrow transplantation. J Clin Immunol 1995; 15: 137.
41. Grekas D, Alivanis P, Kiriazopoulou V, et al. Influenza vaccination on renal transplant patients is safe and serologically effective. Int J Clin Pharmacol Ther Toxicol 1993; 31: 553.
42. Rastogi S, Gross PA, Bonelli J, et al. Time to peak serum antibody response to influenza vaccine. Clin Diagn Lab Immunol 1995; 2: 120.
43. Ghendon Y. The immune response to influenza vaccines. Acta Virol 1990; 34: 295.
44. Powers DC. Effect of age on serum immunoglobulin G subclass antibody responses to inactivated influenza virus vaccine. J Med Virol 1994; 43: 57.
45. Lo W, Whimbey E, Elting L, Couch R, Cabanillas F, Bodey G. Antibody response to a two-dose influenza vaccine regimen in adult lymphoma patients on chemotherapy. Eur J Clin Microbiol Infect Dis 1993; 12: 778.
46. Engelhard D, Nagler A, Hardan I, et al. Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients. Bone Marrow Transplant 1993; 11: 1.
47. Huzly D, Neifer S, Reinke P, et al. Routine immunizations in adult renal transplant recipients. Transplantation 1997; 63: 839.
48. Barra A, Cordonnier C, Preziosi MP, et al. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone marrow recipients. J Infect Dis 1992; 166: 1021.
49. Rand EB, McCarthy CA, Whitington PF. Measles vaccination after orthotopic liver transplantation. J Pediatr 1993; 123: 87.
50. Jacobson IM, Jaffers G, Dienstag JL, et al. Immunogenicity of hepatitis B vaccine in renal transplant recipients. Transplantation 1985; 39: 393.
51. Mond JJ, Lees A, Snapper CM. T-cell-independent antigens type-2. Annu Rev Immunol 1995; 13: 655.
52. Fedson DS. Pneumococcal vaccine. In: Plotkin SA, Mortimer EAJ, eds. Vaccines. Philadelphia: WB Saunders, 1988; 271.
53. Huang KL, Armstrong JA, Ho M. Antibody response after influenza immunization in renal transplant patients receiving cyclosporin A or azathioprine. Infect Immun 1983; 40: 421.
54. Mauch TJ, Crouch NA, Freese DK, Braunlin EA, Dunn DL, Kashtan CE. Antibody response of pediatric solid organ transplant recipients to immunization against influenza virus. J Pediatr 1995; 127: 957.
55. Fletcher TJ, Tunnicliff WS, Hammond K, Roberts K, Ayres JG. Simultaneous immunisation with influenza vaccine and pneumococcal polysaccharide vaccine in patients with chronic respiratory disease. Br Med J 1997; 314: 1663.